- Home
- DPG vs MLAB Comparison
DPG vs MLAB Comparison
Compare DPG & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DPG | MLAB |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 535.3M | 489.8M |
| IPO Year | 2011 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DPG | MLAB |
|---|---|---|
| Price | $14.42 | $87.35 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $94.00 |
| AVG Volume (30 Days) | ★ 108.1K | 79.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | N/A | ★ 99.24 |
| EPS | N/A | ★ 1.95 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.07 |
| Revenue Next Year | N/A | $5.41 |
| P/E Ratio | ★ N/A | $45.03 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.45 | $59.63 |
| 52 Week High | $14.96 | $134.96 |
Technical Indicators
Market Signals| Indicator | DPG | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 55.66 | 43.98 |
| Support Level | $12.37 | $85.91 |
| Resistance Level | $14.68 | $89.69 |
| Average True Range (ATR) | 0.22 | 4.48 |
| MACD | -0.06 | -0.98 |
| Stochastic Oscillator | 24.68 | 23.35 |
Price Performance
Historical ComparisonAbout DPG Duff & Phelps Utility and Infrastructure Fund Inc.
Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund, and its objective is to seek total return, derived mainly from a high level of current income, with an emphasis on providing tax-advantaged dividend income and growth in current income, and secondarily from capital appreciation.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.